Patent · US Expired

Treatment of tension-type headaches with NMDA receptor antagonists

US6649605B2 · kind B2 · utility

30Cited by
1References
51Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 30, 2001
Grant dateNov 18, 2003
Priority date—
Expiry dateNov 19, 2021

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

NMDA receptor antagonists, especially mirtazapine, can be used to treat tension-type headaches.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.